Table II.
Parameter/Day | Control-median (IQR) | p-value | |
---|---|---|---|
PAS | Plasma | ||
LTA ADP (%), 1 | 22 (9–38) | 23 (16–57) | 0.60 |
LTA ADP (%), 3 | 2 (0–3) | 3 (2.5–4.5) | 0.25 |
LTA ADP (%), 5 | 4 (3–8) | 3 (2–3) | 0.28 |
p-value | 0.011 | 0.009 | |
CT EXTEM (sec), 1 | 78 (71–94) | 59 (49–59) | 0.11 |
CT EXTEM (sec), 3 | 61 (59–78) | 63.5 (46.5–72.5) | 0.53 |
CT EXTEM (sec), 5 | 69 (55–74) | 59 (45–61) | 0.46 |
p-value | 0.42 | 0.90 | |
CFT EXTEM (sec), 1 | 53 (43–60) | 45 (45–47) | 0.46 |
CFT EXTEM (sec), 3 | 55 (53–58) | 42 (38–54) | 0.14 |
CFT EXTEM (sec), 5 | 61 (61–64) | 46 (45–58) | 0.027 |
p-value | 0.34 | 0.55 | |
A10 EXTEM (mm), 1 | 62 (55–63) | 66 (66–67) | 0.09 |
A10 EXTEM (mm), 3 | 53 (51–58) | 59.5 (57–62) | 0.08 |
A10 EXTEM (mm), 5 | 54 (51–55) | 52 (52–53) | 0.83 |
p-value | 0.10 | 0.004 | |
MCF EXTEM (mm), 1 | 66 (58–67) | 68 (68–69) | 0.07 |
MCF EXTEM (mm), 3 | 53 (52–59) | 60 (57–63) | 0.14 |
MCF EXTEM (mm), 5 | 54 (51–56) | 52 (52–53) | 0.91 |
p-value | 0.041 | 0.004 | |
MCE EXTEM, 1 | 198 (138–202) | 215 (212–227) | 0.07 |
MCE EXTEM, 3 | 114 (110–143) | 151.5 (133.5–172) | 0.14 |
MCE EXTEM, 5 | 119 (104–125) | 110 (110–115) | 0.91 |
p-value | 0.059 | 0.004 |
p-values in bold stand for statistically significant results (p<0.05). IQR: interquartile range; LTA: light transmission aggregometry; EPI: epinephrine; ADP: adenosine diphosphate; CT: clotting time; CFT: clot formation time; A10: amplitude 10 min after CT; A20: amplitude 20 min after CT; A30: amplitude 30 min after CT; MCF: maximum clot firmness; LI60:lysis index at 60 minutes; MCE: maximum clot elasticity.